Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Positron Q3 2026 Results: Net Loss of $972K, Loss Narrows

Positron Corp filed its Form 10-Q for the quarterly period ended September 30, 2026, detailing its financial performance and operational progress in the molecular imaging industry. The report highlights the company's focus on its PET imaging systems and the development of its radiopharmaceutical business segments.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.10.1
Gross profit-0.4-0.3
Net income-1.0-1.0
EPS (diluted, $ a share)$-0.03$-0.03

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-7.5%
Gross margin-379.3%
Source

10-Q filed with the SEC, OTC: POSC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Positron Corp: key numbers

Share price
$1.63Close, Nov 16
Market cap
$53.9M
Shares outstanding
33.1MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic ApparatusSIC 3845

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Positron Corp

All →
4:54 PM ET 8-K
Loan & Debt

Positron $2M Debt Financing with George Ortiz

Positron Corporation issued three unsecured promissory notes in the aggregate principal amount of $2.0 million to affiliated and third-party investors. The notes bear 20% annual interest and mature on September 30, 2027, with the company also issuing warrants to purchase 400,000 shares of common stock as additional consideration for the financing.

Value
$2M
Counterparty
George Ortiz
Term
1 year

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.